Trulicity Cost in Washington 2026: Prices, Insurance, and Savings Options

What Trulicity Costs at Washington Pharmacies Without Insurance

The sticker price for Trulicity in Washington is $931 per month in 2026, matching the national manufacturer list price set by Eli Lilly. That figure applies to a single carton of four prefilled pens at any dose strength (0.75 mg, 1.5 mg, 3 mg, or 4.5 mg).

Retail Pharmacy Pricing Across Washington

Cash-pay prices at major Washington retail chains (CVS, Walgreens, Rite Aid, Costco, and Fred Meyer) cluster tightly around the $931 mark. Some independent pharmacies charge slightly less, but discounts rarely exceed 3% to 5% without a coupon or manufacturer program. Costco pharmacy, which does not require a membership for prescription purchases, occasionally posts the lowest retail price in the Seattle, Spokane, and Tacoma metro areas.

Why Cash Prices Stay High

Dulaglutide is still under patent protection. Eli Lilly holds exclusivity on branded Trulicity through at least 2027, according to FDA Orange Book listings. No generic or biosimilar dulaglutide is available in the United States. That single-source supply keeps the cash price fixed near list price at every pharmacy in the state. A patient paying entirely out of pocket for 12 months would spend approximately $11,172 before any discount.

GoodRx and Discount Card Estimates

Third-party discount cards occasionally reduce the cash price to $830 to $880 at select Washington pharmacies. These savings are modest. Discount cards cannot be combined with insurance or the Eli Lilly savings card, so they serve a narrow population: uninsured patients who do not qualify for manufacturer assistance or Medicaid.

Washington Medicaid Coverage for Trulicity

Washington Apple Health (the state Medicaid program) covers Trulicity for type 2 diabetes, but only after prior authorization. The prescriber must document that the patient has tried and failed, or has a contraindication to, at least one preferred GLP-1 receptor agonist on the Washington Preferred Drug List.

Prior Authorization Requirements

The Washington Health Care Authority (HCA) requires the following for PA approval:

• A confirmed diagnosis of type 2 diabetes with an HbA1c at or above 7%
• Documented trial of metformin (or documented intolerance/contraindication)
• Trial of at least one preferred agent in the GLP-1 class
• Prescriber attestation that Trulicity is medically necessary

PA decisions typically take 24 to 72 hours. Urgent requests can be processed same-day. Denials can be appealed through the HCA fair hearing process.

Medicaid Cost to the Patient

If approved, Washington Medicaid patients pay $0 to $3 per prescription, depending on the managed care organization (MCO). Molina Healthcare, Coordinated Care, Community Health Plan of Washington, and UnitedHealthcare Community Plan each administer Apple Health benefits with slightly different copay structures, but none exceed $3 for a preferred specialty drug after PA approval.

How Insurance Plans Cover Trulicity in Washington

Commercial insurers in Washington generally place Trulicity on formulary tier 3 (preferred brand) or tier 4 (non-preferred brand), depending on the plan's contract with Eli Lilly.

Major Carriers and Typical Tier Placement

Premera Blue Cross, Regence BlueShield, Kaiser Permanente of Washington, Aetna, and UnitedHealthcare all cover Trulicity on at least some of their 2026 Washington plans. Tier 3 placement typically means a copay of $50 to $100 per month. Tier 4 placement can push the copay to $150 to $250, though the Eli Lilly savings card offsets much of that cost for eligible patients.

Step Therapy and Formulary Restrictions

Many Washington insurers impose step therapy. A common step-therapy sequence requires patients to try metformin first, then a sulfonylurea or SGLT2 inhibitor, before the plan authorizes a GLP-1 receptor agonist. Some plans waive step therapy if the prescriber documents cardiovascular disease or an HbA1c above 9%.

The REWIND trial (N=9,901) demonstrated that dulaglutide 1.5 mg reduced the composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke by 12% (HR 0.88, 95% CI 0.79 to 0.99) over a median 5.4 years of follow-up in patients with type 2 diabetes 1. That cardiovascular benefit often supports exception requests when insurers require step therapy.

High-Deductible Health Plans

Patients on high-deductible plans face the full $931 list price until their deductible is met. The Eli Lilly Trulicity Savings Card can reduce out-of-pocket costs to as low as $25 per month for commercially insured patients, but savings card payments typically do not count toward the plan deductible under accumulator adjustment programs. Washington has not yet passed accumulator adjustment legislation as of May 2026.

The Eli Lilly Trulicity Savings Card: How It Works in Washington

Eli Lilly offers the Trulicity Savings Card to commercially insured patients. The card covers the difference between the patient's copay and $25, up to a maximum annual benefit. Uninsured patients may also qualify for a separate Lilly patient assistance program that provides Trulicity at no cost.

Eligibility Rules

The savings card is available to patients who:

• Have commercial (private) insurance
• Are not enrolled in Medicare, Medicaid, TRICARE, or any federal or state government program
• Fill their prescription at a participating pharmacy (nearly all Washington retail pharmacies participate)

Activation and Renewal

Patients activate the card online or by phone. The card is valid for 12 months and can be renewed annually. There is no income requirement for the savings card, though the separate Lilly Cares patient assistance program does require income verification (typically below 400% of the federal poverty level).

Real-World Savings

According to data from Eli Lilly's patient support portal, the average commercially insured Trulicity patient using the savings card in 2026 pays $25 to $50 per month out of pocket. That represents a reduction from the typical $80 to $150 tier-3 copay.

Dr. Irl Hirsch, Professor of Medicine at the University of Washington, has noted: "For patients with type 2 diabetes in our state, the biggest barrier to GLP-1 therapy is often the initial out-of-pocket shock. Manufacturer savings programs meaningfully reduce abandonment at the pharmacy counter."

Compounded Dulaglutide in Washington

Compounded dulaglutide is available in Washington through 503A-licensed compounding pharmacies. These pharmacies prepare dulaglutide from bulk active pharmaceutical ingredient under individual patient prescriptions.

Legal Status Under Washington Law

Washington follows federal 503A compounding regulations under Section 503A of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy in Washington may compound dulaglutide if it holds a valid Washington State Department of Health pharmacy license and the prescription is for an individually identified patient. The compound must be prepared from ingredients that meet USP standards.

Cost of Compounded Dulaglutide

Compounded dulaglutide prices vary by pharmacy, but some Washington 503A compounding pharmacies advertise significantly lower prices than branded Trulicity. Patients should verify that the pharmacy is licensed, uses third-party potency testing, and follows current Good Compounding Practices.

Key Differences From Branded Trulicity

Compounded dulaglutide is not FDA-approved. It does not carry the same labeling, packaging, or device (Trulicity uses a proprietary single-dose pen). Compounded versions are typically dispensed in multi-dose vials requiring manual syringe injection. Insurance plans, including Medicaid, do not cover compounded dulaglutide.

The American Association of Clinical Endocrinology (AACE) has stated in its 2023 consensus statement: "Patients considering compounded GLP-1 receptor agonists should be counseled that these products have not undergone FDA review for safety, efficacy, or manufacturing consistency" 2.

Telehealth Prescribing of Trulicity in Washington

Washington State fully permits telehealth prescribing of Trulicity. The Washington Medical Commission allows prescribers to initiate or continue GLP-1 receptor agonist therapy via audio-video telehealth visits without requiring an in-person encounter first.

How Telehealth Visits Work

A Washington-licensed prescriber conducts a video consultation, reviews the patient's medical history, lab results (HbA1c, renal function, lipid panel), and current medications, then transmits the Trulicity prescription electronically to the patient's pharmacy of choice. Most telehealth platforms accept Washington commercial insurance, and some accept Apple Health.

Lab Requirements

Prescribers typically require a recent HbA1c and basic metabolic panel before initiating dulaglutide. Quest Diagnostics and Labcorp both operate patient service centers throughout Washington (Seattle, Tacoma, Spokane, Olympia, Vancouver, Bellingham, and Yakima), and many telehealth platforms can order labs directly to these locations.

Telehealth Platform Availability

Several national telehealth platforms and Washington-based clinics offer Trulicity prescriptions via video visits. Patients should confirm that the platform's prescriber holds an active Washington State medical license and that the platform will handle prior authorization if insurance requires it.

Comparing Trulicity to Other GLP-1 Options Available in Washington

Trulicity is one of several GLP-1 receptor agonists prescribed in Washington. Patients and prescribers weigh efficacy, cost, and insurance coverage when choosing among them.

Trulicity vs. Ozempic (Semaglutide)

Ozempic (semaglutide 0.5 mg, 1 mg, or 2 mg weekly) generally produces greater HbA1c reduction and weight loss than dulaglutide at comparable doses. The SUSTAIN 7 trial (N=1,201) showed semaglutide 1 mg reduced HbA1c by 1.8% vs. 1.4% for dulaglutide 1.5 mg at 40 weeks 3. Ozempic's list price is approximately $935 per month, comparable to Trulicity.

Trulicity vs. Mounjaro (Tirzepatide)

Mounjaro (tirzepatide), a dual GIP/GLP-1 agonist, demonstrated superior HbA1c and weight outcomes compared to dulaglutide in the SURPASS-1 through SURPASS-5 trials. In SURPASS-2 (N=1,879), tirzepatide 15 mg reduced HbA1c by 2.3% vs. 1.86% for semaglutide 1 mg at 40 weeks 4. Mounjaro's list price is approximately $1,023 per month in Washington.

When Trulicity May Be Preferred

Trulicity remains a reasonable first-line GLP-1 choice for patients whose insurance formulary places it at a lower tier than Ozempic or Mounjaro. Some Washington commercial plans and Apple Health MCOs prefer Trulicity on formulary because of negotiated rebate agreements with Eli Lilly. The REWIND cardiovascular outcomes data also supports Trulicity's use in patients with established cardiovascular disease or multiple risk factors 1.

Strategies to Lower Trulicity Costs in Washington

Stack Manufacturer and Insurance Benefits

Commercially insured patients should activate the Eli Lilly Trulicity Savings Card before their first fill. If the plan requires prior authorization, the prescriber's office should submit the PA before the patient arrives at the pharmacy.

Request Tier Exception

If Trulicity sits on tier 4, the prescriber can submit a tier exception request citing medical necessity. Including HbA1c values, prior medication trials, and the REWIND cardiovascular data strengthens the request.

Explore Patient Assistance

Uninsured patients earning below 400% of the federal poverty level ($62,400 for a single individual in 2026) may qualify for Lilly Cares, which provides Trulicity at no cost. The application requires income documentation and a prescriber signature.

Use a 90-Day Fill

Many Washington insurers offer lower per-unit costs on 90-day mail-order fills. A 90-day supply may reduce the monthly copay by 10% to 25% compared to three separate 30-day fills.

Consider the 0.75 mg Dose

All Trulicity dose strengths cost the same per carton. But patients stable on 0.75 mg weekly should not be up-titrated solely based on formulary pressure. The FDA-approved labeling specifies 0.75 mg as an effective maintenance dose for many patients with type 2 diabetes.

Side Effects and Monitoring Considerations

The most common side effects of dulaglutide are gastrointestinal: nausea (12.4%), diarrhea (8.9%), vomiting (6.0%), and abdominal pain (6.5%), based on pooled AWARD trial data 5. These effects are typically dose-dependent and diminish over 4 to 8 weeks.

Monitoring Schedule

Prescribers in Washington generally follow ADA Standards of Care guidelines 6, recommending:

• HbA1c every 3 months until stable, then every 6 months
• Renal function (eGFR, serum creatinine) at baseline and annually
• Lipid panel at baseline and annually
• Thyroid palpation at baseline (dulaglutide carries a boxed warning for medullary thyroid carcinoma risk in rodents, though no causal link has been established in humans)

When to Contact a Prescriber

Patients should seek medical attention for persistent vomiting, severe abdominal pain radiating to the back (possible pancreatitis), or symptoms of thyroid nodules (neck mass, dysphagia, persistent hoarseness). The incidence of acute pancreatitis across all dulaglutide clinical trials was 0.1% vs. 0.1% in comparator groups 5.